09/16/2024
7:46 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:47 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:48 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:49 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:50 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:47 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:49 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/13/2024
3:49 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:50 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:57 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:05 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
5:13 PM | Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:35 PM | Mereo BioPharma Group (Subject)
PAKIANATHAN DEEPIKA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:19 AM | Mereo BioPharma Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
7:09 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
10:46 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
06/27/2024
3:15 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:13 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:13 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:14 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:21 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
5:53 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024
5:58 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144/A | |
06/24/2024
6:00 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024
6:04 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144/A | |
06/24/2024
6:04 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/20/2024
3:27 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:30 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:32 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:34 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:16 PM | Mereo BioPharma Group (Issuer)
Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Crypto Crash Ahead? (27 Experts Weigh In) (Ad) Your Portfolio Could Be at RISK
Emergency summit reveals crypto could save you! Click here to reserve your spot at the emergency crypto summit now. |
06/11/2024
8:15 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2024
11:15 PM | Mereo BioPharma Group (Filer)
| Form EFFECT | |
05/23/2024
8:54 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:38 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:49 PM | Mereo BioPharma Group (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/15/2024
3:19 PM | Mereo BioPharma Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:36 AM | Mereo BioPharma Group (Filer)
| Form ARS | |
04/24/2024
6:30 AM | Mereo BioPharma Group (Filer)
| Form DEF 14A | |
04/16/2024
1:58 PM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
04/15/2024
6:30 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
4:20 PM | Mereo BioPharma Group (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
5:51 PM | Mereo BioPharma Group (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
1:11 PM | Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024
11:36 AM | MANGROVE PARTNERS IM, LLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
02/13/2024
4:26 PM | Mereo BioPharma Group (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
4:09 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
01/23/2024
3:16 PM | Mereo BioPharma Group (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
6:08 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:16 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:17 PM | Mereo BioPharma Group (Issuer)
Shames Daniel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:18 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Bender Jeremy (Reporting)
Mereo BioPharma Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Roberts Justin Hunter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Yoskowitz Marc J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Jacquet Pierre (Reporting)
Mereo BioPharma Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Mereo BioPharma Group (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Jenkins Annalisa (Reporting)
Mereo BioPharma Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:15 PM | Fox Chrisitne Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:16 PM | Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2023
3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-A12B/A | |
11/29/2023
3:15 PM | Mereo BioPharma Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2023
7:45 AM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/16/2023
6:01 AM | Mereo BioPharma Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023
6:56 AM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/13/2023
6:31 AM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/08/2023
6:06 AM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/06/2023
6:30 AM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
11/02/2023
6:30 AM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
